THC Therapeutics IncOver The Counter Market:THCT
- LAST PRICE0.0046
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0046
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
THC Therapeutics Inc | 185.0K | -0.3x | --- |
Hollund Industrial Marine Inc | 5.3K | --- | --- |
GrowLife Inc | 5.5K | 0.0x | --- |
Transakt Ltd | 2.7M | -12.8x | --- |
Concrete Leveling Systems Inc | 9.0M | -135.9x | --- |
Hyzon Motors Inc | 12.9M | 0.0x | --- |
Company Information
THC Therapeutics, Inc. is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The dHydronator can also reduce the bacterial count of the cannabis during the drying process. The Company operates in the wellness industry.
Contact Information
- Headquarters
- 11700 W CHARLESTON BLVD #73LAS VEGAS, NV, United States 89135
- Phone
- 702-602-8422
- Fax
- ---
Executives
- President, Company Secretary, Director
- Brandon Romanek
- Interim Chief Executive Officer, Director
- Scott Cox
- Head of Design
- Victor Nacif
- Medical Director
- John Pierce
- Lead Researcher
- Natalia Tafur
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $185.0K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 40.2M |
THC Therapeutics Inc does not pay a dividend. | |
Beta | 1.83 |
EPS | $-0.02 |
Book Value | $-0.10 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
